2004 Epilepsy Patients 
The Cannigma
OCTOBER 10, 2021
Greek drug laws have gone through a series of amendments since the passing of law nº 1729/87 in 1987, which had at its core a view of drug addicts as patients as opposed to criminals. A survey carried out in 2004 found that 8.6% What Greek law permits for medical patients? overall had used cannabis. Is CBD legal in Greece?
The Joint Blog
FEBRUARY 24, 2021
Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s? Though trialing is relatively new and there is no clear scientific evidence as of yet, anecdotal evidence from patients is looking positive. This is not the first medicinal trial of its kind.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 28, 2020
The different approaches on the legality of cultivation and use of (medical) cannabis in the member states have led to a policy paradox within the European Union, causing complications for patients in several member states.
Canna Care Docs
NOVEMBER 23, 2020
Initiative 65 (74%) passed over the Alternative 65A (32%)—the latter of which would have restricted medicinal cannabis to terminally ill patients. Medicinal cannabis was already approved in Montana in 2004. The passing initiative legalizes cannabis prescriptions for 22 medical conditions.
The Cannigma
OCTOBER 8, 2021
The United Kingdom legalized medical cannabis in November 2018 but the program is the subject of criticism regarding access to medicine and approval of patients. The UK government made the decision i n 2004 to reclassify cannabis from a Class B to Class C drug, but the decision was rescinded in 2009.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.
Cannabis Law Report
JULY 12, 2019
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.
Expert insights. Personalized for you.
98 
Let's personalize your content